W. Ripley Ballou - Concepedia

Author

W. Ripley Ballou

Also Known As

W Ripley Ballou, W. RIPLEY BALLOU, W. Ripley Ballou, W.RIPLEY BALLOU, W.Ripley Ballou, W. Ripley Ballou, W. Ripley Ballou, Jr., William Ripley Ballou, William Ripley Ballou

Publications

10K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Belgium)Walter Reed Army Institute of Research U.S. President's Malaria Initiative GlaxoSmithKline (United Kingdom)Universitat de Barcelona

About

W. Ripley Ballou is an author at GlaxoSmithKline (Belgium) specializing in medicine, vaccination, and malaria.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	27	4.2K
2	Allergy	2	2	64
3	Biomolecular Engineering	2	2	240
4	Health Sciences	1	1	21
5	Public Health	1	1	137

W. Ripley Ballou

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial Pedro L. Alonso, Jahit Sacarlal, John J. Aponte, The Lancet VaccinationVaccine SafetyPlasmodium Falciparum InfectionVaccine DevelopmentMalaria	2004	746
Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam, The Journal of Infectious Diseases	2009	533
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial Kalifa Bojang, Paul Milligan, Margaret Pinder, The Lancet VaccinationPlasmodium Falciparum InfectionRandomised TrialMalariaImmunology	2001	526
SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE W. Ripley Ballou, Stephen L. Hoffman, James A. Sherwood, The Lancet VaccinationVaccine SafetyVaccine DevelopmentMalariaPolyvalent Vaccine	1987	425
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age Philip Bejon, John Lusingu, Ally Olotu, New England Journal of Medicine	2008	412
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial Pedro L. Alonso, Jahit Sacarlal, John J. Aponte, The Lancet VaccinationPlasmodium Falciparum DiseaseGlobal HealthMalariaPediatrics	2005	410
A Field Trial to Assess a Blood-Stage Malaria Vaccine Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly, New England Journal of Medicine	2011	358
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA Katie Ewer, Tommy Rampling, Navin Venkatraman, New England Journal of Medicine	2015	353
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya Bernhards Ogutu, Odika J. Apollo, Denise McKinney, PLoS ONE	2009	341
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans Dmitri Kazmin, Helder I. Nakaya, Eva K. Lee, Proceedings of the National Academy of Sciences	2017	297

Page 1